Pharmacology of Rifampicin

Introduction/Overview Rifampicin, also known as rifampin in some regions, represents a cornerstone antimicrobial agent within the modern pharmacotherapeutic arsenal. As a semisynthetic derivative of rifamycin B, produced by Streptomyces mediterranei, its introduction revolutionized the treatment of tuberculosis and other mycobacterial infections. The clinical importance of rifampicin extends beyond its direct bactericidal activity, as its potent … Read more

Pharmacology of Cotrimoxazole

Introduction/Overview Cotrimoxazole represents a fixed-dose combination antimicrobial agent consisting of sulfamethoxazole and trimethoprim in a 5:1 ratio. This synergistic combination has maintained clinical utility for over five decades despite the continuous evolution of antimicrobial resistance. The drug’s broad-spectrum activity against a diverse array of bacterial, protozoal, and fungal pathogens underpins its continued relevance in both … Read more

Pharmacology of Ciprofloxacin

Introduction/Overview Ciprofloxacin is a synthetic chemotherapeutic agent belonging to the fluoroquinolone class of antibiotics. Since its introduction in the 1980s, it has represented a cornerstone in the management of a broad spectrum of bacterial infections due to its potent bactericidal activity, favorable pharmacokinetic profile, and availability in both oral and intravenous formulations. Its development marked … Read more

Pharmacology of Chloramphenicol

Introduction/Overview Chloramphenicol is a broad-spectrum antibiotic first isolated from Streptomyces venezuelae in 1947. It represents a historically significant antimicrobial agent whose clinical use has become markedly restricted in many parts of the world due to its association with serious, potentially fatal hematological toxicities. Despite this, it retains a crucial therapeutic role in specific, often life-threatening … Read more

Pharmacology of Azithromycin

Introduction/Overview Azithromycin represents a cornerstone antimicrobial agent within the macrolide class, distinguished by its unique pharmacokinetic profile and broad spectrum of activity. As a semi-synthetic derivative of erythromycin, it was developed to overcome limitations associated with earlier macrolides, particularly gastrointestinal intolerance and a short elimination half-life. The clinical introduction of azithromycin significantly expanded therapeutic options … Read more

Pharmacology of Tetracycline

1. Introduction/Overview Tetracyclines represent a broad-spectrum class of antibiotics with a history spanning over seven decades of clinical use. Originally derived from Streptomyces bacteria, these agents have played a significant role in the management of diverse infectious diseases, from common bacterial infections to complex zoonotic and protozoan illnesses. Their clinical relevance persists despite the emergence … Read more

Pharmacology of Gentamicin

Introduction/Overview Gentamicin, a bactericidal aminoglycoside antibiotic, represents a cornerstone in the management of serious Gram-negative bacterial infections. First isolated from Micromonospora purpurea in 1963, its introduction marked a significant advancement in antimicrobial therapy, particularly for infections caused by Pseudomonas aeruginosa and other resistant pathogens. Despite the development of newer antimicrobial classes, gentamicin maintains critical clinical … Read more

Pharmacology of Vancomycin

Introduction/Overview Vancomycin is a tricyclic glycopeptide antibiotic of considerable historical and contemporary clinical significance. Initially isolated from Streptomyces orientalis in the 1950s, it was long considered a drug of last resort due to its perceived toxicity and the efficacy of alternative agents like ฮฒ-lactams. However, the global proliferation of multidrug-resistant Gram-positive pathogens, particularly methicillin-resistant Staphylococcus … Read more

Pharmacology of Ceftriaxone

Introduction/Overview Ceftriaxone is a broad-spectrum, third-generation cephalosporin antibiotic of paramount clinical importance in modern antimicrobial therapy. Its development represented a significant advancement in the beta-lactam class, addressing the need for agents with enhanced stability against bacterial beta-lactamases, improved Gram-negative coverage, and a pharmacokinetic profile conducive to convenient dosing regimens. The drug’s extended half-life, which permits … Read more

Pharmacology of Amoxicillin

Introduction/Overview Amoxicillin is a semisynthetic aminopenicillin antibiotic derived from the basic penicillin nucleus, 6-aminopenicillanic acid. It represents one of the most frequently prescribed antibacterial agents worldwide, serving as a cornerstone in the empirical and definitive treatment of a broad spectrum of community-acquired bacterial infections. Its development in the early 1970s marked a significant advancement over … Read more